PVJ is an open-access video journal. Content is intended for healthcare professionals.

Home/Conferences/RCPCH Conference 2024

Pressing play loads the video from YouTube. Privacy

Are referrals for suspected paediatric bone and soft tissue tumours meeting the two week standard?

Key points

  • The audit checked whether national cancer pathway timelines were met for seeing, diagnosing and treating patients, using data from January to December 2022.
  • The hospital was quite compliant in seeing and diagnosing patients, but there was some delay in providing treatment.
  • Many benign osteochondroma cases are being seen, and a separate pathway for them is being discussed so other cases can be seen quicker.

Binod Pander, Royal National Orthopaedic Hospital, discusses his work in identifying if cancer pathway standards are being met in a tertiary referral centre in London. The standards are being adhered to in terms of reviewing patients within the two week time frame and diagnosing within 28 days. However, a delay was identified in initiation of cancer treatment. Furthermore, lots of cases of benign osteochondroma have been identified as potentially leading to delay for other more important cases. Further discussions are needed to streamline the pathway for these benign cases. This interview took place at the RCPCH conference 2024 in Birmingham, UK.

Read the transcript

Automatic transcript, lightly edited for readability. It may contain errors, so check it against the video before quoting.

My poster, it's about an audit where we wanted to see if we are meeting national cancer pathway guidelines in terms of seeing the patient within the timeline, diagnosing within the time and making treatment within the time. Our hospital receives referrals from the south east of England, and the paediatric department sees all the GP referrals. So our aim was seeing if we are seeing the patient within 2 weeks of referral, and if diagnosing them within the first 28 days, and treating them within the first 2 months of referral.

So we did data collection from January 2022 to December 2022. With our data, what we found out is we're quite compliant in terms of seeing them, in terms of diagnosing, but there's some delay in providing treatment, and we're looking into the possible cause. There's some delay in diagnosing, difficulties in getting results with biopsies, that's one of the causes.

One other thing that we find from this analysis is that we're getting a lot of cases of osteochondroma, benign cases, and we're discussing if a separate pathway can be made for treating these cases so that we can see the other cases quicker. So that's the basic thing, please.

Topics

Share

Cite this video

Binod Pander. “Are referrals for suspected paediatric bone and soft tissue tumours meeting the two week standard?.” The Paediatric Video Journal, 30 December 2024. https://paediatricvj.com/videos/are-referrals-for-suspected-paediatric-bone-and-soft-tissue-pander/

This interview is educational content intended for healthcare professionals and is not medical advice. Views expressed are those of the speaker. © The Paediatric Video Journal. All rights reserved.